Prostate cancer on the rise in 2022
Prostate cancer is a very common diagnosis. Did you know prostate cancer is estimated to be the second most common cancer diagnosis in American men?According to the American Cancer Society, the number of newly diagnosed prostate cancer patients will increase by 8% and forecasts over 34,000 prostate cancer related deaths in 20221.
Move through cancer with confidence
If you’re newly diagnosed with prostate cancer, or have already been treated for it, there are simple genetic tests that offer peace of mind and greater hope.
Myriad genetic testing can show if you inherited a mutation that may have caused your cancer, and whether your family members have an elevated risk. And if you’ve previously been treated for prostate cancer, testing can identify your risk of developing a secondary cancer in the future.